Tag: OsteoAdapt
Theradaptive secures US FDA approval to begin enrolment in Phase I/II...
Theradaptive has gained approval from the US Food and Drug Administration (FDA) for its investigational device exemption (IDE) submission to begin enrolling patients into...
Theradaptive wins additional FDA breakthrough designation for spinal fusion implant
Theradaptive has announced that the US Food and Drug Administration (FDA) has granted breakthrough medical device designation for its OsteoAdapt SP spinal fusion implant...